AlphAIalphai — Financial news for AI agents
financialcontent.comJUL 293 min read$MMSI

Earnings To Watch: Merit Medical Systems (MMSI) Reports Q2 Results Tomorrow

Merit Medical Systems (NASDAQ: MMSI) is set to report Q2 earnings Thursday after the bell. The company previously reported $381.9 million revenue, up 7.5% year over year, and beat EPS and full-year EPS guidance. For the upcoming quarter, analysts expect revenue growth of about 6% y/y. MMSI has an average analyst price target of $90.09 versus $78.29.

Original reporting
financialcontent.com
Published Jul 29, 2026, 4:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 4:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Earnings To Watch: Merit Medical Systems (MMSI) Reports Q2 Results Tomorrow — source image
Source · financialcontent.com
Decision brief

The 30-second read

$MMSINeutralMed
01

Why it matters

Traders can use the stated consensus (6% YoY revenue growth) and the prior-quarter beat history to position for earnings-day volatility, but there is no new company-specific disclosure in the text.

02

Market read

Provides consensus expectations and peer reaction context ahead of the earnings catalyst.

03

What to watch

The preview does not include margin, cash flow, backlog, or guidance details, which are often the true drivers of post-earnings repricing.

Relevance 4/10Novelty 4/10Timing: Thursday after the bell earnings release.

Background

The piece is an earnings preview for Merit Medical Systems’ Q2 results scheduled for Thursday after the bell.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

Merit Medical Systems is set to report Q2 results after the bell Thursday, with consensus expecting 6% YoY revenue growth.

Expected impact

Likely elevated pre- and after-hours volatility; direction depends on whether reported revenue/EPS beat the reconfirmed Street expectations.

Evidence & confidence

The article provides specific consensus expectations and prior-quarter beat context, but it does not disclose any new earnings datapoint or guidance change beyond what is already expected.

Market effects

Sector

Healthcare equipment and supplies sentiment is described as positive, which can influence read-across positioning into earnings season.

Regional

No specific regional impact described.

Global

No global macro or cross-border catalyst described.

Counterpoint

What could challenge this read

If the company’s revenue growth deceleration (13.2% to 6% YoY) is sharper than expected, the stock could sell off even with a modest beat.

Key entities

  • company
    Merit Medical Systems

    NASDAQ-listed medical device company reporting Q2 results Thursday after the bell.

  • company
    Intuitive Surgical

    Peer cited for its Q2 reaction (down 14.1% after results).

  • company
    Abbott Laboratories

    Peer cited for its Q2 reaction (up 12.8% after results).

Read at source← All news

Related articles

AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min
JUL 30
$MMSIHigh

MERIT MEDICAL SYSTEMS INC (MMSI): Results of Operations and Financial Condition

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@i

SEC EDGAR 8-K6 min
AUG 8
$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

yahoo.com6 min